Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/17525
DC FieldValueLanguage
dc.contributor.authorKristina Miticen_US
dc.contributor.authorAna Kaftandzievaen_US
dc.contributor.authorMirjana Popovskaen_US
dc.contributor.authorKiro Ivanovskien_US
dc.contributor.authorMaja Pandilovaen_US
dc.contributor.authorSilvana Georgievaen_US
dc.contributor.authorSnezana Pesevskaen_US
dc.contributor.authorAneta Atanasovska-Stojanovskaen_US
dc.contributor.authorBiljana Kapusevskaen_US
dc.contributor.authorEdvard Janeven_US
dc.contributor.authorAneta Mijovskaen_US
dc.date.accessioned2022-05-05T08:25:28Z-
dc.date.available2022-05-05T08:25:28Z-
dc.date.issued2017-06-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/17525-
dc.description.abstractThe aim of this study was to evaluate the effects of probiotic lozenges as an adjunct to scaling and root planing (SRP) in chronic periodontitis patients. Thirty chronic periodontitis patients divided in examined group (SRP+ probiotic, n=15) and control group (SRP, n=15), were monitored clinically (plaque index(PI), the gingival index(GI), the probing pocket depth(PD), clinical attachment level(CAL) and microbiological parameters were recorded on day 0, and 1 month after therapy. The Prolife lozenges containing: Bacillus coagulans (Lactobacillus sporogenes), Lactobacillus acidophilus, Streptococcus thermophilus, Lactobacillus bulgaricus, Bifidobacterium bifidum (≥ 2,1 x 109), were used two times a day for 15 days. PI and GI were significantly reduced in both groups (p < 0.05) after the treatment. PD in examined group of 4,93 0,7mm decreased to 3,960,8 mm (p>0,05), versus mean PD of 5,2  0,7 mm in control group that was equally after the treatment (p>0,05). CAL gains of 4,21,3 mm to 3,861,3mm in the examined group versus 4,361,2 mm to 4,2 1,2 (p>0,05) in control group. Microbiological examination demonstrated decreased of quantum of above 100 bacterial colonies of anaerobes and facultative anaerobes, from 66,7% to 33,3% in the examined group, according to 53,3% to 46,7% in control group. Despite data indicate an effect of probiotics on the oral microbiota and a more limited effect on clinical periodontal outcome measures, it can be recommended as a useful adjunct to SRP in chronic periodontitis patients.en_US
dc.language.isoenen_US
dc.relation.ispartofResearch Journal of Pharmaceutical, Biological and Chemical Sciencesen_US
dc.subjectLactobacillusen_US
dc.subjectPeriodontitisen_US
dc.subjectProbioticsen_US
dc.subjectScaling and root planningen_US
dc.titleProbiotics and Oral Healthen_US
dc.typeArticleen_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Dentistry-
crisitem.author.deptFaculty of Dentistry-
crisitem.author.deptFaculty of Dentistry-
crisitem.author.deptFaculty of Dentistry-
crisitem.author.deptFaculty of Dentistry-
crisitem.author.deptFaculty of Dentistry-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
RJPBCS-Probiotics and oral health-2017.pdf1.1 MBAdobe PDFView/Open
Show simple item record

Page view(s)

75
checked on Oct 10, 2024

Download(s)

32
checked on Oct 10, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.